Fig. 3From: Immunohistochemistry of advanced glycation end product Nε-(carboxymethyl)lysine in coronary arteries in relation to cardiac fibrosis and serum N-terminal-pro basic natriuretic peptide in forensic autopsy casesThe CML immunohistochemistry in relation to hypertension, hyperlipidemia, heart disease as the cause of death (COD), diabetes mellitus, and HbA1c. The right axis shows the number of cases. Asterisks show the statistically significant difference in disease cases, compared with non-disease cases by Chi square test. The histories of hypertension and hyperlipidemia showed the statistically significant difference in CML immunohistochemistry grades. The heart disease (ischemic heart disease, congestive heart failure, or cardiomegaly) as COD showed no statistically significant difference. The history of diabetes mellitus (DM) and HbA1c showed no statistically significant difference in CML immunohistochemistry gradesBack to article page